Definitive Contract 75D30123C18129
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded an $11,542 firm fixed price purchase order to Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, to conduct follow up of seed participants in California. As the prime contractor, Kaiser Permanente will perform the work itself in Atlanta, Georgia under the one year contract running from September 2022 through December 2023. The Centers for...
- This $1,986,836.74 firm fixed-price federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract, awarded on July 1, 2021, supports FY 2021 Broad Agency Announcement (BAA) Topic 9 - KPSC, with a period of performance ending on September 30, 2022. This contract is not set aside for any small business categories. Kaiser Permanente...
- This federal contract award to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, is valued at $1,772,230.00. It was awarded by the Centers for Disease Control and Prevention (CDC) on April 9, 2020 and has an ultimate completion date of August 6, 2023. The contract is for "INNOVATIVE METHODS TO INFORM ESTIMATES OF VACCINE EFFECTIVENESS USING INFORMATION" and is a firm fixed-price definitive contract. No set-aside was used....
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The contract, valued at $434,957, is a definitive, firm-fixed price contract with a completion date of June 29, 2019. Kaiser Permanente, a non-profit healthcare provider, has a long history of supporting federal agencies like the CDC, the Food and Drug Administration, and the National Institutes of...
- CDC Pittsburgh awarded a $5.7 million definitive contract to Kaiser Foundation Hospitals, operating as Kaiser Permanente through its Kaiser Foundation Research Institute division, for a virtual network to investigate the clinical epidemiology of influenza and the effectiveness of influenza vaccines on September 30, 2023. The contract is sole-source; the solicitation states that only Kaiser Permanente Southern California can satisfy the requirement due to its current participation in CDC's...
- This is a definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for a prospective observational cohort study to assess the effectiveness of SARS-CoV-2 vaccines. The $55,223,588.00 contract has an ultimate completion date of December 31, 2024 and is a cost-no-fee arrangement. The contract does not have a set-aside designation. Kaiser Permanente is collaborating with the University of...
- <p>The Centers for Disease Control and Prevention awarded a purchase order to Kaiser Foundation Hospitals (Kaiser Permanente) for $150,000 on July 26, 2024, under a firm fixed-price contract ratifying FY 21 BAA Topic 9-KPSC. Work is performed in Oakland, California, with an ultimate completion date of August 1, 2024. The purchase order supports research activities through Kaiser Foundation Research Institute, the awardee's research division.</p>
- CDC Pittsburgh awarded a $1.13 million definitive contract to Kaiser Foundation Hospitals for the purchase of aggregated PrEP prescription data on September 1, 2022, under a sole-source justification. Kaiser Foundation Hospitals is the sole entity holding the requested regional PrEP prescription data needed to meet CDC's surveillance and evaluation objectives. The originating solicitation, posted March 8, 2022, sought annual aggregated PrEP use data tables extracted from three Kaiser regions...
- This is a purchase order award by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization doing business as Kaiser Permanente. The $116,746 firm fixed-price contract, awarded on September 30, 2015, is for unspecified products or services with a completion date of December 31, 2016. The award is not set aside for any particular type of business. Kaiser Permanente is an established federal contractor that...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a division of the Kaiser Foundation Research Institute, doing business as Kaiser Permanente. The contract does not have a set-aside designation. The contract, valued at $116,534, is for IMPACT OF HPV research. Kaiser Permanente, a non-profit healthcare provider and research organization, has extensive experience supporting federal public health...
The Centers for Disease Control and Prevention awarded a $11.47 million definitive contract to Kaiser Foundation Hospitals (Kaiser Foundation Research Institute / Kaiser Permanente) for epidemiology studies support services on September 29, 2023, with ultimate completion on September 28, 2028, under firm fixed-price terms and no set-aside. The originating solicitation (75D301-23-R-72697) required access to large-scale de-identified electronic medical record data covering millions of US patients and full medical records for specified studies. Kaiser Permanente is expected to collaborate with CDC to design and implement epidemiological analyses investigating disease trends and emerging threats, completing up to five studies per year on an as-needed basis. Place of performance is Oakland, California. This contract was one of up to five anticipated awards made on an indefinite delivery/indefinite quantity basis for a five-year period (one base year and four option years). NAICS code 541715 applies. Under Service Contract Inventory reporting, Kaiser Permanente invoiced $97 thousand in FY2023 (76 contractor hours), $1.1 million in FY2024 (2.5 FTEs, 5,119 contractor hours at a derived rate of $206.30 per hour), and $3.2 million in FY2025 (2.3 FTEs). The prime self-performed all reported hours with no subcontractors.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
CDC/CFA Epidemiology Studies | 75D301-23-R-72697 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Award Notice 2/2 | 9/28/23, 12:59 PM | |
CDC/CFA Epidemiology Studies | 75D301-23-R-72697 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Solicitation 1/2 | 7/24/23, 8:21 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 6/8/26 | |
| P00001 | Exercise an Option | $2.3m | 6/5/24 | |
| Not listed | Not listed | $1.9m | 9/27/23 |